Metal nanoparticles may improve cancer treatment

Nov 30, 2012
Metal nanoparticles may improve cancer treatment
The research team developed a detector to measure the radiation dose in three dimensions.

Research led by RMIT University has shown that cheap, non-toxic nanoparticles can enhance radiotherapy treatments for cancer.

An international team of researchers led by RMIT has investigated alternatives to , which have been shown to concentrate used to treat cancer but are highly expensive and mildly toxic.

Doctoral researcher Mamdooh Alqathami said the team had identified bismuth as an ideal option, with tests showing that enhancing radiotherapy by using nanoparticles containing the heavy metal almost doubled the dose of radiation to surrounding .

"By enhancing radiation in the tumour, doctors may be able to decrease the initial dose of radiotherapy, which will hopefully result in fewer side effects for the patient while having the same impact on the cancer," Mr Alqathami, a researcher in the School of Medical Sciences, said.

" have shown promise in improving the efficacy of radiotherapy but there is a need to find cheaper and safer alternatives for therapeutic use.

"Bismuth-based nanoparticles are an attractive option as they cost only a few dollars per gram, compared with thousands of dollars a gram for gold, and they are non-toxic, reducing any side effects from potential treatments.

"While further work needs to be done before our findings can be implemented into conventional cancer treatments, this is an exciting advance that gives us a promising focus for ongoing research."

Mr Alqathami collaborated with researchers from RMIT's Health Innovations Research Institute, the University of Melbourne, the University of Surrey (UK) and the Institute of Cancer Research (UK) on the study.

To test the efficacy of bismuth, Mr Alqathami placed the nanoparticles inside a detector developed by his team to measure the radiation dose in .

The sample and detector was exposed to radiation that would normally be used to treat cancers. The final dose delivered was then compared with normal treatments, showing the bismuth-based nanoparticles increased the by 90 per cent.

The team is planning further tests to validate the findings and fully understand the dosage increase, to enable the findings to be implemented in treatment.

This research was presented at the International Conference on 3D Radiation Dosimetery recently held in Sydney.

Explore further: Understanding the source of extra-large capacities in promising Li-ion battery electrodes

add to favorites email to friend print save as pdf

Related Stories

A promising step forward in prostate cancer treatment

Aug 06, 2012

When treating prostate cancer with radiotherapy, knowing the prostate cancer position is critical to accurately targeting the radiation beam to avoid missing the tumour and irradiating healthy tissue. Prostate cancer patients ...

NPL unveils new equipment to make cancer treatment safer

Nov 14, 2008

A new piece of medical technology unveiled at the National Physical Laboratory (NPL) today will help improve the success rates of radiotherapy cancer treatments. The new clinical electron linear accelerator (linac) will help ...

Recommended for you

Graphene surfaces on photonic racetracks

23 hours ago

In an article published in Optics Express, scientists from The University of Manchester describe how graphene can be wrapped around a silicon wire, or waveguide, and modify the transmission of light through it.

Simulating the invisible

23 hours ago

Panagiotis Grammatikopoulos in the OIST Nanoparticles by Design Unit simulates the interactions of particles that are too small to see, and too complicated to visualize. In order to study the particles' behavior, he uses ...

Building 'invisible' materials with light

Jul 28, 2014

A new method of building materials using light, developed by researchers at the University of Cambridge, could one day enable technologies that are often considered the realm of science fiction, such as invisibility ...

User comments : 0